/
/
/

Sanjivani Paranteral Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
₹24 Cr₹13 Cr₹22 Cr₹15 Cr₹18 Cr₹18 Cr₹17 Cr₹18 Cr₹16 Cr₹13 Cr₹15 Cr₹14 Cr
₹15 L₹60 L₹30 L₹16 L₹4 L₹43 L₹31 L₹39 L₹9 L₹5 L₹25 L₹15 L
₹24 Cr₹14 Cr₹22 Cr₹16 Cr₹18 Cr₹19 Cr₹18 Cr₹19 Cr₹17 Cr₹13 Cr₹15 Cr₹14 Cr
₹20 Cr₹12 Cr₹18 Cr₹13 Cr₹15 Cr₹16 Cr₹15 Cr₹15 Cr₹14 Cr₹11 Cr₹13 Cr₹12 Cr
₹4 Cr₹2 Cr₹4 Cr₹2 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr
₹35 L₹31 L₹21 L₹5 L₹22 L₹20 L₹19 L₹18 L₹2 L₹9 L₹8 L₹5 L
₹3 Cr₹1 Cr₹4 Cr₹2 Cr₹2 Cr₹3 Cr₹3 Cr₹3 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr
₹2 Cr₹55 L₹3 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr₹2 Cr₹2 Cr

Share Price Live Stats

Open (₹)189.00
Volume (₹)91,679.00
High (₹)197.00
Upper Circuit223.40
Low (₹)185.00
Lower Circuit149.00
Prev Close186.20
52W High (₹)268.00
Price195.00
52W Low (₹)126.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)228.73 Cr
Div. Yield (%)0.00
PE Ratio30.63
Debt to Equity0.22
Price to Book7.77
Book Value30.83
EPS (TTM)6.08
Face Value10.00
ROE (%)25.90

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
ZYDUSLIFE-ANSE
CIPLA-ANSE
LAURUSLABS-ANSE
LUPIN-ANSE
MANKIND-ANSE
DRREDDY-ANSE
AUROPHARMA-ANSE
SANJIVIN-XNSE
LTP
1W Low
1W High
Market cap (₹)
1881.1-17.9 (-0.94%)
1876.95
1924.90
4,55,826Cr
9570.55+470.55 (5.17%)
9100
9593.05
2,47,019Cr
4962.75+112.75 (2.32%)
4822.25
4982.35
1,86,875Cr
1150+29 (2.59%)
1110.55
1167.20
1,15,212Cr
1383.95-1.05 (-0.08%)
1375.85
1398
1,12,773Cr
1945.5+105.5 (5.73%)
1826.95
1951.15
1,00,944Cr
2112+1 (0.05%)
2095
2149.75
96,255Cr
2305.85-22.7 (-0.97%)
2301.30
2368
95,911Cr
1151.5-2.5 (-0.22%)
1142.55
1165.75
95,571Cr
1686+32.7 (1.98%)
1623.05
1699
95,398Cr
195+5.4 (2.85%)
185
197.85
229Cr

Key Highlights of Sanjivani Paranteral Ltd’s P&L

In 2025-03-31, Sanjivani Paranteral Ltd reported total revenue of ₹71.39Cr, compared with ₹55.15Cr in 2024-03-31, reflecting Sanjivani Paranteral Ltd turnover.

Depreciation was ₹62.09Lakh and finance costs were ₹59.27Lakh in 2025-03-31

Profit Before Tax (PBT) has been ₹10.35Cr in 2025-03-31 as compared to ₹7.57Cr in 2024-03-31.

Net Profit (PAT) was ₹8.1Cr in 2025-03-31 compared with ₹6.17Cr in 2024-03-31.

Earnings per share (EPS) were ₹6.81 in 2025-03-31, compared with ₹5.28 in 2024-03-31.